AMORPHOUS COMPOUND
The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascula...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BROWN, JOHN ROBERTS, RONALD, JOHN |
| description | The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.
La présente invention concerne une nouvelle forme de (S)-1-[N -(1-carboxy-3-phénylpropyle)-L-lysyle]-L-proline connue sous le nom générique de lisinopril. De plus, la présente invention concerne également l'utilisation de la nouvelle forme amorphe de lisinopril pour le traitement de l'hypertension et d'autres maladies cardiovasculaires, des compositions pharmaceutiques la contenant ainsi que des procédés de préparation de la nouvelle forme amorphe de lisinopril. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO03000716A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO03000716A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO03000716A23</originalsourceid><addsrcrecordid>eNrjZBBy9PUPCvDwDw1WcPb3DfAP9XPhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx4f4GxgYGBuaGZo5GxsSoAQBSfB5M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMORPHOUS COMPOUND</title><source>esp@cenet</source><creator>BROWN, JOHN ; ROBERTS, RONALD, JOHN</creator><creatorcontrib>BROWN, JOHN ; ROBERTS, RONALD, JOHN</creatorcontrib><description>The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.
La présente invention concerne une nouvelle forme de (S)-1-[N -(1-carboxy-3-phénylpropyle)-L-lysyle]-L-proline connue sous le nom générique de lisinopril. De plus, la présente invention concerne également l'utilisation de la nouvelle forme amorphe de lisinopril pour le traitement de l'hypertension et d'autres maladies cardiovasculaires, des compositions pharmaceutiques la contenant ainsi que des procédés de préparation de la nouvelle forme amorphe de lisinopril.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030103&DB=EPODOC&CC=WO&NR=03000716A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030103&DB=EPODOC&CC=WO&NR=03000716A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BROWN, JOHN</creatorcontrib><creatorcontrib>ROBERTS, RONALD, JOHN</creatorcontrib><title>AMORPHOUS COMPOUND</title><description>The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.
La présente invention concerne une nouvelle forme de (S)-1-[N -(1-carboxy-3-phénylpropyle)-L-lysyle]-L-proline connue sous le nom générique de lisinopril. De plus, la présente invention concerne également l'utilisation de la nouvelle forme amorphe de lisinopril pour le traitement de l'hypertension et d'autres maladies cardiovasculaires, des compositions pharmaceutiques la contenant ainsi que des procédés de préparation de la nouvelle forme amorphe de lisinopril.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBy9PUPCvDwDw1WcPb3DfAP9XPhYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx4f4GxgYGBuaGZo5GxsSoAQBSfB5M</recordid><startdate>20030103</startdate><enddate>20030103</enddate><creator>BROWN, JOHN</creator><creator>ROBERTS, RONALD, JOHN</creator><scope>EVB</scope></search><sort><creationdate>20030103</creationdate><title>AMORPHOUS COMPOUND</title><author>BROWN, JOHN ; ROBERTS, RONALD, JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO03000716A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2003</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BROWN, JOHN</creatorcontrib><creatorcontrib>ROBERTS, RONALD, JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BROWN, JOHN</au><au>ROBERTS, RONALD, JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMORPHOUS COMPOUND</title><date>2003-01-03</date><risdate>2003</risdate><abstract>The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.
La présente invention concerne une nouvelle forme de (S)-1-[N -(1-carboxy-3-phénylpropyle)-L-lysyle]-L-proline connue sous le nom générique de lisinopril. De plus, la présente invention concerne également l'utilisation de la nouvelle forme amorphe de lisinopril pour le traitement de l'hypertension et d'autres maladies cardiovasculaires, des compositions pharmaceutiques la contenant ainsi que des procédés de préparation de la nouvelle forme amorphe de lisinopril.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO03000716A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | AMORPHOUS COMPOUND |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T04%3A06%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BROWN,%20JOHN&rft.date=2003-01-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO03000716A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |